• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[碳酸锂的长期给药:基于一例长达25年锂治疗病例的经验]

[Long-term administration of lithium carbonate: experience based on a case of 25-year-long treatment with lithium].

作者信息

Rybakowski J, Chłopocka-Woźniak M

机构信息

Kliniki Psychiatrii Dorosłych AM w Poznaniu.

出版信息

Psychiatr Pol. 1996 Sep-Oct;30(5):731-40.

PMID:8984514
Abstract

In the beginning of 1960s, initial reports appeared pointing to a possibility of preventing depressive and manic recurrences in affective illness by means of long-term administration of lithium salts. Subsequent several years of controlled studies confirmed such prophylactic effect of lithium in affective illness beyond any doubt. Some patients in whom lithium administration was started in the beginning of 1970s may, by now, have received lithium for more than twenty years. The patient reported in the present paper, had began lithium treatment on April 1, 1971, after her third depressive episode since 1965. During 25 years of uninterrupted lithium carbonate administration in daily dose 1000 mg (for 5 years-750 mg) and with mean serum lithium concentration 0.6 mmol/l, the recurrences have not been observed, mental status was normal and professional (physician-ophthalmologist) and family functioning was good. Either somatic or mental side-effects have not occurred. Twenty five years of the patient's lithium treatment, was paralleled by important events for lithium therapy such as, i.a., autobiographies of prominent persons receiving lithium for porphylactic purposes, definition of a new category of psychotropic drugs (normothymic) with lithium as a prototype, establishing some mechanism of lithium action on intracellular transmission, discovery of antiviral and immunomodulatory effect of lithium as well as finding of decreased mortality of patients receiving long-term lithium therapy.

摘要

20世纪60年代初,最初有报告指出,通过长期服用锂盐有可能预防情感性疾病中的抑郁和躁狂复发。随后几年的对照研究毫无疑问地证实了锂在情感性疾病中的这种预防作用。一些在20世纪70年代初开始服用锂的患者,到现在可能已经服用锂超过20年了。本文所报道的患者在1965年以来第三次抑郁发作后,于1971年4月1日开始锂治疗。在连续25年每日服用1000毫克碳酸锂(5年中为750毫克)且平均血清锂浓度为0.6毫摩尔/升的情况下,未观察到复发,精神状态正常,职业(眼科医生)和家庭功能良好。未出现躯体或精神副作用。患者25年的锂治疗与锂治疗的一些重要事件同时发生,例如,一些知名人士接受锂预防性治疗的自传、以锂为原型定义了一类新的精神药物(心境稳定药)、确立了锂对细胞内传递的一些作用机制、发现了锂的抗病毒和免疫调节作用以及发现长期接受锂治疗的患者死亡率降低。

相似文献

1
[Long-term administration of lithium carbonate: experience based on a case of 25-year-long treatment with lithium].[碳酸锂的长期给药:基于一例长达25年锂治疗病例的经验]
Psychiatr Pol. 1996 Sep-Oct;30(5):731-40.
2
[Pseudo-hallucinations after long-term lithium treatment].
Nervenarzt. 1993 Nov;64(11):747-9.
3
Lithium carbonate in juvenile manic-depressive illness.碳酸锂治疗青少年躁郁症。
Dis Nerv Syst. 1976 Feb;37(2):90-2.
4
Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation.中年及老年成年患者亚群中锂盐治疗单相和双相抑郁症的情况。
Depress Anxiety. 2007;24(8):571-6. doi: 10.1002/da.20273.
5
[Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration].[一组持续接受精神药物治疗的受试者治疗依从性中的自主性态度]
Encephale. 2002 Sep-Oct;28(5 Pt 1):389-96.
6
[Late onset first manic episode: role of lithium].
Encephale. 2001 Jul-Aug;27(4):377-9.
7
[Results of long-term (over 10 years) lithium therapy].
Psychiatr Pol. 1996 Jul-Aug;30(4):583-91.
8
[Lithium in the prevention of affective disorders: 20 years' experience].
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl. 1989;32(5):625-32.
9
[Use of long-acting lithium carbonate--micalite--in the treatment of affective psychoses].[长效碳酸锂——云母岩——在情感性精神病治疗中的应用]
Zh Nevropatol Psikhiatr Im S S Korsakova. 1977;77(4):583-7.
10
Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.奥氮平:新适应症。双相情感障碍的预防:试验结果缺乏说服力。
Prescrire Int. 2005 Aug;14(78):140-2.